Jesup & Lamont

Jesup & Lamont was a historic Wall Street brokerage and investment banking firm founded in 1877. While the firm was not a biotechnology or pharmaceutical developer, it was well-known in the life sciences sector for providing specialized equity research, investment banking, and capital raising services for small-to-mid-cap healthcare companies. The firm operated for over 130 years before facing severe financial distress during the post-2008 financial crisis. In 2010, the Financial Industry Regulatory Authority (FINRA) ordered the firm to cease operations due to net capital violations, effectively ending its business activities. It is primarily relevant to biotech analysts as a historical underwriter and research provider for early-stage clinical companies.